Vapor Inhaler Inhalant
Product Images NDC 41163-031

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vapor Inhaler (NDC 41163-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Supervalu Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (198 mg Blister Pack Label)

Principal Display Panel (198 mg Blister Pack Label)
This text is describing a nasal decongestant product called Vicks VapoInhaler. The product consists of levmetamfetamine, which is used for temporary relief from nasal congestion caused by common cold, hay fever or upper respiratory allergies. The product provides 0.04 to 0.150mg of levmetamfetamine in every 800 milliliters of air. It is recommended to use the product no more than every 2 hours, and the use of this container by more than one person may spread infection. The product is not recommended for use for more than 7 days, and prolonged use may cause nasal congestion to recur or worsen. It is not suitable for children under 2 years of age. The inhaler is effective for at least 3 months after first use and should be stored between 59 and 89 degrees Fahrenheit. If symptoms persist, it is recommended to stop using the product and consult a doctor.*
FDA Label Image

Principal Display Panel (198 mg Blister Pack Label)

Principal Display Panel (198 mg Blister Pack Label)
The EQQUALINE nasal decongestant vapor inhaler contains levmetamfetamine as an active ingredient that helps provide temporary relief from nasal congestion caused by allergies, colds, and hay fever. The product should be used only as directed to avoid spreading infections or worsening nasal congestion. The inhaler is effective for at least three months after first use and should be kept tightly closed and stored between 59°-89° F (15°-30° C). Children under two years of age should not use the inhaler, and pregnant or nursing individuals should consult a healthcare professional first. Some common side effects may include burning, sneezing, or increased nasal discharge. In case of persistent symptoms or ingestion, immediate medical assistance is recommended. For inquiries or comments, call SUPVERVALU INC. in Eden Prairie, MN, USA, at 1-877-932-7948.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.